On August 4, Paylocity Holding Corporation (NASDAQ:PCTY) closed the books on a fiscal 2026 that most software companies would ...
On 8, Spyre Therapeutics (NASDAQ:SYRE) announced that SPY003, its anti-IL-23 antibody, hit its primary endpoint in Part A of ...
On September 9, COPT Defense Properties (NYSE:CDP) told investors it had already leased 408,000 square feet of vacant space ...
On August 6, StandardAero (NYSE:SARO) reported second-quarter results that leaned harder on margin than on revenue, and the ...
On August 4, Timken (NYSE:TKR) reported second-quarter results that read like two different stories depending on which line ...
On August 4, Central Bancompany (NASDAQ:CBC) reported second-quarter results that topped both the prior quarter and the ...
On0, StoneX Group (NASDAQ:SNEX) and DeltaTerra Investments rolled out a synthetic credit structure built around Agency ...
On September 3, SentinelOne (NYSE:S) expanded its Wayfinder Frontier AI Services with new tools built on OpenAI ...
On August 17, Mosaic Biosciences, a unit of The Mosaic Company (NYSE:MOS), launched Renuvis Enzara, an enzyme-based treatment ...
SEALSQ Corp (NASDAQ:LAES) disclosed a $32.2 million operating loss for the six months ended June 30, 2026, versus $21.2 ...
4h
Exelixis (EXEL) Faces a Three-Month Zanzalintinib Review Extension. Can the Data Support Approval?
Exelixis, Inc. (NASDAQ:EXEL) disclosed in a September 11 filing that the FDA had extended the review of zanzalintinib by ...
Cellectis S.A. (NASDAQ:CLLS) announced on September 14 that its board approved a strategic transformation on September 11.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results